Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin vs Dapoxetine for Primary Premature Ejaculation
NCT07081659Phase 3Completed
- Sponsor
- Benha University
- Start
- Mar 2024
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of silodosin in premature ejaculation (PE) (2 arms), sponsored by Benha University. Primary endpoint: Intravaginal Ejaculatory Latency Time at 2 months. Started Mar 2024; status: completed.
02
Drugs
silodosin
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT07081659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07081659.